Literature DB >> 2651162

Putative precursors of endothelin have less vasoconstrictor activity in vitro but a potent pressor effect in vivo.

T Kashiwabara1, Y Inagaki, H Ohta, A Iwamatsu, M Nomizu, A Morita, K Nishikori.   

Abstract

Endothelin (ET-21) induced a sustained contraction of rat thoracic aortae (EC50 = 2.65 x 10(-10) M) in vitro, and caused a potent pressor effect in vivo after intravenous administration to rats. In contrast, the precursor deduced from porcine cDNA coding ET-21 (pET-39) had 100-fold less contractile activity in vitro (EC50 = 3.26 x 10(-8) M), and so did the precursor from human cDNA (hET-38) (EC50 = 1.48 x 10(-8) M). However, both pET-39 and hET-38 caused almost the same dose-dependent pressor effects as ET-21 in vivo. After intravenous bolus injection at 1 nmol/kg, ET-21 caused an initial transient drop of the arterial pressure, and then induced a gradual pressor effect. On the other hand, hET-38 caused only a gradual rise of the arterial pressure. There may be different mechanism(s) for ET-21 and hET-38 which induce changes in the arterial pressure in vivo.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2651162     DOI: 10.1016/0014-5793(89)81243-8

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  19 in total

1.  Contractile effect of big endothelin-1 and its conversion to endothelin-1 in rabbit cerebral arteries.

Authors:  J Petersson; G C Hanson; B F Lindberg; E D Högestätt
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1996-11       Impact factor: 3.000

2.  Modulation of human colon tumor-stromal interactions by the endothelin system.

Authors:  G Egidy; L Juillerat-Jeanneret; J F Jeannin; P Korth; F T Bosman; F Pinet
Journal:  Am J Pathol       Date:  2000-12       Impact factor: 4.307

3.  Differential effects of phosphoramidon on contractile responses to angiotensin II in rat blood vessels.

Authors:  L Chen; J R McNeill; T W Wilson; V Gopalakrishnan
Journal:  Br J Pharmacol       Date:  1995-04       Impact factor: 8.739

4.  Comparison of the cardiovascular and neural activity of endothelin-1, -2, -3 and respective proendothelins: effects of phosphoramidon and thiorphan.

Authors:  G G Mattera; A Eglezos; A R Renzetti; J Mizrahi
Journal:  Br J Pharmacol       Date:  1993-09       Impact factor: 8.739

5.  Comparison of haemoconcentration induced by big endothelin-1 and endothelin-1 in mice.

Authors:  H Okumura; N Ashizawa; F Kobayashi; K Arai; R Asakura; N Ashikawa; A Matsuura
Journal:  Br J Pharmacol       Date:  1993-12       Impact factor: 8.739

6.  Cross tachyphylaxis to endothelin isopeptide-induced hypotension: a phenomenon not seen with proendothelin.

Authors:  A C Le Monnier de Gouville; I Cavero
Journal:  Br J Pharmacol       Date:  1991-09       Impact factor: 8.739

7.  The endothelin-converting enzyme from human umbilical vein is a membrane-bound metalloprotease similar to that from bovine aortic endothelial cells.

Authors:  K Ahn; K Beningo; G Olds; D Hupe
Journal:  Proc Natl Acad Sci U S A       Date:  1992-09-15       Impact factor: 11.205

8.  Presence of a phosphoramidon-sensitive endothelin-converting enzyme which converts big-endothelin-1, but not big-endothelin-3, in the rat vas deferens.

Authors:  S Télémaque; P D'Orléans-Juste
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1991-10       Impact factor: 3.000

9.  Different pharmacological profiles of big-endothelin-3 and big-endothelin-1 in vivo and in vitro.

Authors:  P D'Orléans-Juste; S Télémaque; A Claing
Journal:  Br J Pharmacol       Date:  1991-10       Impact factor: 8.739

10.  Endothelium-dependent vascular activities of endothelin-like peptides in the isolated superior mesenteric arterial bed of the rat.

Authors:  S A Douglas; C R Hiley
Journal:  Br J Pharmacol       Date:  1990-09       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.